Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975].
Pharmacol Res. 2023 Mar;189:106708. doi: 10.1016/j.phrs.2023.106708. Epub 2023 Mar 2.
Pharmacol Res. 2023.
PMID: 36868967
Free article.
No abstract available.
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein.
Abd-Ellatef GEF, Gazzano E, El-Desoky AH, Hamed AR, Kopecka J, Belisario DC, Costamagna C, S Marie MA, Fahmy SR, Abdel-Hamid AZ, Riganti C.
Abd-Ellatef GEF, et al.
Pharmacol Res. 2022 Jan;175:105975. doi: 10.1016/j.phrs.2021.105975. Epub 2021 Nov 14.
Pharmacol Res. 2022.
PMID: 34785319
Free article.
Item in Clipboard
Correction to "Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance".
Chegaev K, Fraix A, Gazzano E, Abd-Ellatef GEF, Blangetti M, Rolando B, Conoci S, Riganti C, Fruttero R, Gasco A, Sortino S.
Chegaev K, et al. Among authors: abd ellatef gef.
ACS Med Chem Lett. 2019 Feb 28;10(3):393. doi: 10.1021/acsmedchemlett.9b00048. eCollection 2019 Mar 14.
ACS Med Chem Lett. 2019.
PMID: 30891147
Free PMC article.
Item in Clipboard
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.
Chegaev K, Fraix A, Gazzano E, Abd-Ellatef GE, Blangetti M, Rolando B, Conoci S, Riganti C, Fruttero R, Gasco A, Sortino S.
Chegaev K, et al.
ACS Med Chem Lett. 2017 Jan 30;8(3):361-365. doi: 10.1021/acsmedchemlett.7b00016. eCollection 2017 Mar 9.
ACS Med Chem Lett. 2017.
PMID: 28337331
Free PMC article.
Item in Clipboard
Ulva lactuca polysaccharides prevent Wistar rat breast carcinogenesis through the augmentation of apoptosis, enhancement of antioxidant defense system, and suppression of inflammation.
Abd-Ellatef GF, Ahmed OM, Abdel-Reheim ES, Abdel-Hamid AZ.
Abd-Ellatef GF, et al.
Breast Cancer (Dove Med Press). 2017 Feb 27;9:67-83. doi: 10.2147/BCTT.S125165. eCollection 2017.
Breast Cancer (Dove Med Press). 2017.
PMID: 28280387
Free PMC article.
Item in Clipboard
Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2/Dox cells.
Yahya SM, Hamed AR, Emara M, Soltan MM, Abd-Ellatef GE, Abdelnasser SM.
Yahya SM, et al.
Tumour Biol. 2016 May;37(5):5925-32. doi: 10.1007/s13277-015-4426-7. Epub 2015 Nov 23.
Tumour Biol. 2016.
PMID: 26596829
Item in Clipboard
Cite
Cite